CRP and inflammatory bowel disease: The failure of biologic therapies among IBD patients has been linked to several factors, such as long disease duration (e.g., >2 years), disease behavior and phenotype, smoking, C-reactive protein (CRP) levels, disease severity, albumin levels, and cytokine expression.